Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...

This chapter illustrates the contribution which could be made to realising the Lisbon Strategy of the European Union for growth and jobs by innovative healthcare policy favouring a preventive orientation of healthcare. The prevention and control of risk factors for chronic diseases, as well as...

This paper investigates cost and profit efficiency of German hospitals. More specifically, it deals with the question how hospital efficiency varies with ownership, patient structure,and other exogenous factors, which are neither inputs nor outputs of the production process. We conduct a...